Author Archives: Dayle
Scientific Sessions Wrap Up
Covering the American Diabetes Association’s Scientific Sessions was once described as “drinking from a fire hose.” This year was no different, so I decided to give the responsibility of wrapping up this year’s Scientific Sessions blog posts to David Kendall, MD, Chief Scientific & Medical Officer at the American Diabetes Association. Continue reading
Scientific Sessions Update: Diabetes Prevention is Cost Effective
While having diabetes has presented me with some great opportunities, I am always an advocate for diabetes prevention because I don’t want anyone else to have to face life with diabetes. A study presented today at the American Diabetes Association’s Scientific Sessions provided another reason to support prevention of type 2 diabetes: it’s cost effective.
Continue reading
Scientific Sessions Update: Advances in Type 1 Treatment
There’s a lot of talk about diabetes prevention. It’s a huge public health topic, and here’s another reason to support it: Prevention of type 1 diabetes. We’re not quite there, but some exciting new drugs in development are showing hope, according to several studies presented today at Scientific Sessions. Continue reading
Scientific Sessions Update: Exploring the Role of Vitamin D in Type 1 and Type 2 Diabetes
There is a lot of talk about vitamin D in the diabetes world – could it really help prevent type 2 diabetes? Does a vitamin D deficiency lead to complications? Researchers at Scientific Sessions are asking the same questions and have presented their findings over the last few days. Continue reading
Scientific Sessions Update: Adapting the Diabetes Prevention Program for Native American Youth
The Diabetes Prevention Program (DPP) was a landmark study published nearly ten years ago that showed that lifestyle changes, such as losing modest amounts of weight and increasing physical activity, could prevent or delay the onset of type 2 diabetes. At nearly 17 percent, American Indians and Alaska Natives have the highest age-adjusted prevalence of diabetes among all U.S. racial and ethnic groups. Researchers presented a study this afternoon at Scientific Sessions that aimed to use the goals of the DPP with tactics that were adapted to be culturally and age appropriate for Native American youth. Continue reading
Scientific Sessions Update: Continuous Glucose Monitoring in the Youngest Patients
Using a continuous glucose monitor (CGM) in young children has not been studied. But researchers, health care professionals, and parents know that glycemic control in children with diabetes is often limited by the fear of hypoglycemia (low blood glucose), but the opposite, hyperglycemia (high blood glucose), can actually contribute to risk for cognitive impairment. Parents are intrigued about whether CGMs could minimize both these risks. Continue reading
Scientific Sessions Update: Cardiovascular Disease Risks Appear Early in Girls with Type 1 Diabetes
Women with type 1 diabetes are at a four times greater risk for cardiovascular disease (CVD) than those who don’t have diabetes. What’s more, pre-menopausal women with diabetes do not seem to have the beneficial effects on heart disease risk factors that other pre-menopausal women have. This morning at the American Diabetes Association’s Scientific Sessions®, researchers presented their findings when they looked at how early in life these risks develop. Continue reading
